Small cap News

AREB is seeing a resurgence in investor interest, helping the stock bounce back from a disappointing 2025.

Market focus shifted toward tariff-related developments alongside upcoming U.S. economic data releases.

Brand Engagement Network announced the finalization of a strategic partnership with Valeo Technologies to establish an exclusive AI licensing framework for government and commercial markets across Africa.

Markets looked to stabilize overnight as investors weighed geopolitical developments amid a busy earnings schedule.

Corvus stated that cohort 4 of its placebo-controlled trial showed favorable safety and efficacy results consistent with results from the previous three cohorts.

In combination with Telegram’s privacy-centric Cocoon AI, AlpaTON said that this positions it to deliver fully vertically integrated, privacy-preserving AI products to Telegram users.

The remarks came as the company faces increased attention following its shift toward a digital-asset treasury model and recent changes to its capital allocation strategy.

An expansion into aerospace and data centers seems to be working well for RF Industries, which is trying to capitalize on the surging demand in these sectors.

The company outlined progress across multiple cancer programs following last week's series of clinical and regulatory updates.

Wall Street opened the week on a cautious note as investors weighed geopolitical uncertainty, shifting risk appetite, and a slew of earnings.

The company said VLX-1005 targets a high-risk heparin complication with limited treatment options.

In its filing, Venus Concept revealed that Madryn Asset Management had acquired a 91% stake in the company, purchasing 18.8 million shares of the company’s common stock.

ARK doubles down on a CRISPR bet as Intellia Therapeutics’ stock heads for its best week since October.

According to a CoinDesk report, Senate committees are planning to get back to the discussion table with crypto industry leaders on Friday, following the bill’s delay earlier this week.

NuScale is seeing increased chatter after Trump’s push for tech giants to share the responsibility in expanding grids soars.

Firefly Aerospace has been firmly on retail investors' radar, with speculation around a potential Golden Dome award emerging as a major upside catalyst for the stock.

A Crypto.com tie-up and a sports-media partnership send High Roller Technologies into overdrive, and onto traders’ radar.

TenX is a recently-listed blockchain infrastructure company, while Bonk aims to bridge the gap between traditional public markets and the digital asset ecosystem.

Chinese authorities have instructed domestic companies not to use cybersecurity software from the banned companies, citing national security concerns.

An unanticipated 1-for-20 reverse stock split announcement drove investor volatility following merger approval.

Hypescale Data’s stock rose nearly 5%, while shares of Sharplink Gaming rose 4% in overnight trade.

RCAT continues to be one of the most-watched stocks on Stocktwits, with retail interest soaring amid a strong quarterly result forecast and building on gains from last week.

AlphaTON stated that these 576 Nvidia B300 GPUs are scheduled for delivery in February.

Kraken-linked SPAC KRAKacquisition files for a $250M Nasdaq IPO under KRAQU, with no merger target yet identified.

Both stocks saw retail sentiment trending in ‘extremely bullish’ territory amid ‘high’ levels of chatter over the past day on Stocktwits.

Stepping into 2026, CRML’s rally is in full steam as recent political developments give the company more reasons to work on its Tanbreez project in the Arctic region.

Instead, Strive’s stock outperformed in after-hours trade ahead of Semler Scientific’s shareholder vote to decide whether the merger between the two companies will go through.

Stocktwits chatter has gone parabolic as American Battery Technology rides a surge in U.S. critical minerals momentum.

Terrestrial Energy is a nuclear energy company that’s beginning to captivate retail traders and investors alike.

In the last 12 months alone, ONDS stock has soared over 500% with no signs of cooling, driven by bullish Wall Street calls and Washington’s growing focus on drones.

Azio AI stated that the company will fulfill a $107 million contract by delivering 256 units of Nvidia B300 GPUs.

Stargardt disease is a form of inherited macular degeneration, affecting more than 100,000 people in the U.S. and Europe combined.

Oklo shares shot up more than 13% by Friday’s midday session after the company announced an agreement with Meta Platforms to advance a 1.2-gigawatt power project in Ohio.

iBio stated that it is selling more than 11 million shares of its common stock at a purchase price of $2.35 apiece.

Poet, which designs and manufactures high-speed optical engines and related photonic components, is still in an early commercial phase.

The updated outlook implies Ardelyx’s lead therapy could reach $1 billion in annual revenue about four years earlier than previously expected.

OLPX shares jumped 24% in five sessions after reports that Henkel-owned Schwarzkopf is in talks with Olaplex on a potential acquisition.

Joseph Todisco’s annual base salary increases to $750,000 from $665,000, effective Jan. 1.

Coinbase shares moved higher after hours after receiving a second Wall Street upgrade this week ahead of quarterly earnings.

Lower mortgage rates are expected to translate to better demand for platforms such as Rocket Companies that manage housing loans and personal financing.

Stocktwits sentiment flipped to ‘extremely bullish’ with message volumes surging, amplified by the company’s rebrand and HQ relocation plans.

Regencell shares are up nearly 218% since October 31, despite the company flagging a “substantial doubt” about its ability to continue as a going concern.

The beauty products marketer stated that it expects FY26 adjusted diluted EPS to be in the range of $3.25 to $3.75, down from its previous forecast of $3.75 to $4.25.

Bottom buyers saw over 2,000% gains, while IPO investors merely broke even after a 90% drawdown, according to Atlas Venture’s Bruce Booth.

After a not-so-great 2025, a push to buy a nuclear company has put PMGC Holdings back on investors’ radar.

A DOE deal, nuclear-friendly policy signals, and roaring retail chatter are propelling IMSR’s comeback.

Terrestrial Energy said it has signed an agreement for Project TETRA, a DOE initiative to construct and operate a pilot reactor that will support IMSR plant development.

Alumis announced positive results from both of its Phase 3 clinical trials of envudeucitinib.

Aeva made multiple platform announcements at the ongoing Consumer Electronics Show 2026.

Zenas stated that it expects to submit a Biologics License Application to the FDA in the second quarter of 2026.